Pharmaceutisch Weekblad

, Volume 8, Issue 1, pp 79–84 | Cite as

Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography

  • A. J. N. Groeneveld
  • J. R. B. J. Brouwers
Original Articles


A simple sensitive HPLC method for the analysis of ciprofloxacin, norfloxacin, ofloxacin and pefloxacin in serum is described. The quinolones were extracted using dichloromethane under neutral conditions, followed by drying under nitrogen and dissolving in mobile phase before Chromatographic analysis. The stationary phase consisted of a stainless steel column with Nucleosil C18 (5 μm), and a mobile phase of 0.04M phosphoric acid, tetrabutylammoniumiodide as ion-pairing reagent and methanol (pH 2.2). UV absorbance was used for detection. The method was shown to be linear, quantitative and reproducible in the therapeutic range of each of these quinolones. Serum levels of ofloxacin and ciprofloxacin were determined and compared to those found by a microbiological assay. Good correlation was found for the assay of ciprofloxacin as well as for ofloxacin.

Key words

Ciprofloxacin High pressure liquid chromatography Microbiological assay Norfloxacin Ofloxacin Pefloxacin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Montay G, Tassel JP. Improved high-performance liquid Chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue. J Chromatogr 1985;339:214–8.Google Scholar
  2. 2.
    Boppana VK, Swanson BN. Determination of norfloxacin. a new nalidixic acid analog, in human serum and urine by high performance liquid chromatography. Antimicrob Agents Chemother 1982;21:808–10.Google Scholar
  3. 3.
    Eandi M, Viano I, Di Nola F, Leone L, Genazzani E. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. Eur J Clin Microbiol 1983;2:253–9.Google Scholar
  4. 4.
    Pauliukonis LT, Musson DG, Bayne WF. Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reversed-phase chromatography. J Pharm Sci 1984;73:99–102.Google Scholar
  5. 5.
    Wolff M, Regnier B, Daldoss C, Nkam M, Vachon F. Penetration of pefloxacin into cerobrospinal fluid of patients with meningitis. Antimicrob Agents Chemother 1984;26:289–91.Google Scholar
  6. 6.
    Aronoff GE, Kenner CH, Sloan RS, Pottratz ST. Multipledose ciprofloxacin kinetics in normal subjects. Clin Pharmacol Ther 1984;36:384–8.Google Scholar
  7. 7.
    Weber A, Chaffin D, Smith A, Opheim KE. Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography. Antimicrob Agents Chemother 1985;27:531–5.Google Scholar
  8. 8.
    Anonymous. Hoechst Investigations Protocol Vol. 1. Amsterdam: Hoechst Holland BV, 1984;4:194–7.Google Scholar
  9. 9.
    Tilly Melin A, Ljungerantz M, Schill G. Reversed-phase ion-pair chromatography with an adsorbing stationary phase and a hydrophobic quaternary ammonium ion in the mobile phase. 1. Retention studies with tetrabutylammonium as cationic component. J Chromatogr 1979;185:225–39.Google Scholar
  10. 10.
    Hoogkamp-Korstanje JAA, Van Oort HJ, Schipper JJ, Van Der Wal T. Intraprostatic concentrations of ciprofloxacin and its activity against urinary pathogens. J Antimicrob Chemother 1984;14:641–5.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1986

Authors and Affiliations

  • A. J. N. Groeneveld
    • 1
  • J. R. B. J. Brouwers
    • 2
  1. 1.Department of Pharmacology and PharmacotherapyState University of GroningenAW GroningenThe Netherlands
  2. 2.Department of Clinical PharmacyGeneral Hospital De TjongerschansPW HeereveenThe Netherlands

Personalised recommendations